Arthi Reddy: Influence Statistics

Arthi Reddy

Arthi Reddy

From the Division of Pediatric Rheumatology, Morgan Stanley Children's Hospital of New York-Presbyterian Hospital/Columbia University Medical Center; New York University ...

Arthi Reddy: Expert Impact

Concepts for which Arthi Reddy has direct influence: Lupus erythematosus , Systemic lupus erythematosus , Efficacy belimumab , Patients sle , Belimumab benlysta , Belimumab sle , Systemic lupus .

Arthi Reddy: KOL impact

Concepts related to the work of other authors for which for which Arthi Reddy has influence: Systemic lupus erythematosus , Belimumab patients , Treatment sle , Lupus nephritis , Maintenance therapy , Biological therapies , Damage progression .

KOL Resume for Arthi Reddy

Year
2015

From the Division of Pediatric Rheumatology, Morgan Stanley Children's Hospital of New York-Presbyterian Hospital/Columbia University Medical Center; New York University Langone Medical Center; Division of Rheumatology, New York-Presbyterian Hospital/Columbia University Medical Center, New York; Hofstra North Shore-LIJ School of Medicine, Hempstead, New York; Medical University of South Carolina, Charleston, South Carolina; Temple University School of Medicine, Philadelphia, Pennsylvania; Johns Hopkins University School of Medicine, Baltimore, Maryland; Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA; Karolinska University Hospital, Stockholm, Sweden; Cedars-Sinai Medical Center, Los Angeles, California, USA.J.S. Hui-Yuen, MD, MSc, Fellow, Division of Pediatric Rheumatology, Morgan Stanley Children's Hospital of New York-Presbyterian Hospital/Columbia University Medical Center; A. Reddy, BSc, Research Assistant, New York University Langone Medical Center; J. Taylor, MD, Pediatric Resident, Division of Pediatric Rheumatology, Morgan Stanley Children's Hospital of New York-Presbyterian Hospital/Columbia University Medical Center; X. Li, BSc, Research Assistant, Division of Rheumatology, New York-Presbyterian Hospital/Columbia University Medical Center; A.H. Eichenfield, MD, Assistant Professor, Division of Pediatric Rheumatology, Morgan Stanley Children's Hospital of New York-Presbyterian Hospital/Columbia University Medical Center; L.M. Bermudez, MD, Fellow, Division of Pediatric Rheumatology, Morgan Stanley Children's Hospital of New York-Presbyterian Hospital/Columbia University Medical Center; A.J. Starr, MD, Assistant Professor, Division of Pediatric Rheumatology, Morgan Stanley Children's Hospital of New York-Presbyterian Hospital/Columbia University Medical Center; L.F. Imundo, MD, Division of Rheumatology, New York-Presbyterian Hospital/Columbia University Medical Center; J. Buyon, MD, Professor, New York University Langone Medical

2013

Nyu School of Medicine

Prominent publications by Arthi Reddy

KOL-Index: 8529 . OBJECTIVE: To evaluate the use and efficacy of belimumab in academic practices. Belimumab is a human monoclonal antibody that inhibits soluble B lymphocyte stimulator and has been approved for the treatment of adults with systemic lupus erythematosus (SLE). METHODS: Invitations to participate and complete a 1-page questionnaire for each patient prescribed belimumab were sent to 16 ...
Known for Lupus Erythematosus | Patients Sle | 6 Months | Onset Antibodies

Key People For Lupus Erythematosus

Top KOLs in the world
#1
David Alan Isenberg
systemic lupus erythematosus patients sle rheumatoid arthritis
#2
Michelle A Petri
systemic lupus erythematosus lupus nephritis patients sle
#3
D Gladman Gladman
psoriatic arthritis systemic lupus erythematosus patients psa
#4
Murray B Urowitz
systemic lupus erythematosus patients sle lupus nephritis
#5
James F Fries
rheumatoid arthritis physical function systemic lupus erythematosus
#6
Eng M Tan
antinuclear antibodies hepatocellular carcinoma cell nuclear antigen

From the Division of Pediatric Rheumatology, Morgan Stanley Children's Hospital of New York-Presbyterian Hospital/Columbia University Medical Center; New York University Langone Medical Center; Division of Rheumatology, New York-Presbyterian Hospital